Literature DB >> 8185386

Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?

P J Sessink1, M C Van de Kerkhof, R B Anzion, J Noordhoek, R P Bos.   

Abstract

In the Netherlands, special guidelines and safety precautions were introduced about 10 y ago for preparation and administration of antineoplastic agents. However, little is known about the effectiveness of these measures. In this study, occupational exposure to antineoplastic agents of nine pharmacy technicians who were involved in drug preparation was investigated. Cyclophosphamide, 5-fluorouracil, and methotrexate accounted for 95% of the antineoplastic agents prepared; therefore, the presence of these compounds was monitored. During preparation, cyclophosphamide was detected in the air of the work environment (< 0.04-10.1 micrograms/m3). Contamination of and permeation through latex gloves were found for each of the three compounds. The uptake of cyclophosphamide was assessed by the determination of cyclophosphamide in urine. The drug was found in urine samples of six pharmacy technicians, including three persons who were not directly involved in the preparation of cyclophosphamide. The amounts excreted ranged from 0.2 to 19.4 micrograms/24 h. The results strongly suggest that inhalation is of minor importance for internal exposure, compared with other, presumably dermal, routes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185386     DOI: 10.1080/00039896.1994.9940377

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  27 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

2.  Inhalation and dermal exposure to eight antineoplastic drugs in an industrial laundry facility.

Authors:  Wouter Fransman; Daan Huizer; Jochen Tuerk; Hans Kromhout
Journal:  Int Arch Occup Environ Health       Date:  2006-10-05       Impact factor: 3.015

3.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

4.  A probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agents.

Authors:  T Meijster; W Fransman; J van Hemmen; H Kromhout; D Heederik; E Tielemans
Journal:  Occup Environ Med       Date:  2006-03-21       Impact factor: 4.402

5.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

6.  Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.

Authors:  Massimo Moretti; Maria Giuseppa Grollino; Sofia Pavanello; Roberta Bonfiglioli; Milena Villarini; Massimo Appolloni; Mariella Carrieri; Laura Sabatini; Luca Dominici; Laura Stronati; Giuseppe Mastrangelo; Anna Barbieri; Cristina Fatigoni; Giovanni Battista Bartolucci; Elisabetta Ceretti; Francesca Mussi; Silvano Monarca
Journal:  Int Arch Occup Environ Health       Date:  2014-11-02       Impact factor: 3.015

7.  Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel.

Authors:  Chun-Yip Hon; George Astrakianakis; Quinn Danyluk; Winnie Chu
Journal:  Can J Hosp Pharm       Date:  2011-09

8.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

9.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

10.  Occupational exposure to cytotoxic drugs in two UK oncology wards.

Authors:  E Ziegler; Howard J Mason; P J Baxter
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.